Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma
1997

Overexpression of Prothymosin Alpha in Liver Cancer

Sample size: 17 publication Evidence: moderate

Author Information

Author(s): C-G Wu, NA Habib, RR Mitry, PH Reitsma, SJH van Deventer, RAFM Chamuleau

Primary Institution: Academic Medical Center, University of Amsterdam

Hypothesis

Is the overexpression of prothymosin alpha correlated with c-myc in patients with hepatocellular carcinoma (HCC)?

Conclusion

Prothymosin alpha mRNA levels are significantly higher in patients with HCC and are correlated with c-myc expression.

Supporting Evidence

  • Prothymosin alpha mRNA levels were two- to 9.2-fold higher in tumoral tissues than in adjacent non-tumoral tissues in 14 of 17 patients with HCC.
  • c-myc mRNA amounts were two- to fivefold increased in 11 of 17 patients with HCC.
  • In situ hybridization revealed that increased prothymosin alpha mRNA was localized in the tumor nodules of patients with HCC.

Takeaway

This study found that a protein called prothymosin alpha is much more present in liver cancer tissues than in healthy tissues, which might help doctors identify liver cancer earlier.

Methodology

The study analyzed mRNA levels of prothymosin alpha and c-myc in liver tissue samples from patients with HCC, cirrhosis, adenoma, and healthy controls using Northern blot analysis.

Limitations

The study had a limited number of patients, which may affect the generalizability of the findings.

Participant Demographics

Patients included 17 individuals with HCC (10 with cirrhosis, 7 without), 4 with hepatic adenoma, 6 with cirrhosis only, and 3 healthy controls.

Statistical Information

P-Value

< 0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication